Veeva Systems Inc. $VEEV Shares Sold by BI Asset Management Fondsmaeglerselskab A S

BI Asset Management Fondsmaeglerselskab A S lessened its holdings in Veeva Systems Inc. (NYSE:VEEV) by 37.6% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 16,846 shares of the technology company’s stock after selling 10,133 shares during the period. BI Asset Management Fondsmaeglerselskab A S’s holdings in Veeva Systems were worth $3,761,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Sivia Capital Partners LLC lifted its holdings in shares of Veeva Systems by 225.9% in the 2nd quarter. Sivia Capital Partners LLC now owns 3,122 shares of the technology company’s stock valued at $899,000 after buying an additional 2,164 shares during the period. Bank of Nova Scotia lifted its holdings in shares of Veeva Systems by 44.5% in the 2nd quarter. Bank of Nova Scotia now owns 5,866 shares of the technology company’s stock valued at $1,689,000 after buying an additional 1,806 shares during the period. NewEdge Advisors LLC lifted its holdings in shares of Veeva Systems by 34.6% in the 2nd quarter. NewEdge Advisors LLC now owns 8,832 shares of the technology company’s stock valued at $2,543,000 after buying an additional 2,272 shares during the period. Treasurer of the State of North Carolina lifted its holdings in shares of Veeva Systems by 2.2% in the 2nd quarter. Treasurer of the State of North Carolina now owns 68,950 shares of the technology company’s stock valued at $19,856,000 after buying an additional 1,452 shares during the period. Finally, Diversify Wealth Management LLC lifted its holdings in shares of Veeva Systems by 5.3% in the 2nd quarter. Diversify Wealth Management LLC now owns 11,399 shares of the technology company’s stock valued at $3,140,000 after buying an additional 575 shares during the period. Institutional investors and hedge funds own 88.20% of the company’s stock.

Veeva Systems Trading Up 0.2%

NYSE VEEV opened at $172.96 on Monday. The stock has a market capitalization of $28.25 billion, a price-to-earnings ratio of 30.83, a PEG ratio of 0.76 and a beta of 0.95. Veeva Systems Inc. has a twelve month low of $148.05 and a twelve month high of $310.50. The stock has a 50-day moving average of $166.17 and a 200 day moving average of $195.17.

Veeva Systems (NYSE:VEEV) last announced its earnings results on Wednesday, June 3rd. The technology company reported $2.24 EPS for the quarter, beating analysts’ consensus estimates of $2.14 by $0.10. Veeva Systems had a return on equity of 13.89% and a net margin of 28.37%.The business had revenue of $882.95 million during the quarter, compared to analysts’ expectations of $857.73 million. During the same quarter in the prior year, the firm earned $1.97 earnings per share. The business’s revenue was up 16.3% compared to the same quarter last year. Veeva Systems has set its FY 2027 guidance at 9.050-9.050 EPS and its Q2 2027 guidance at 2.210-2.220 EPS. Equities analysts predict that Veeva Systems Inc. will post 6.46 EPS for the current fiscal year.

Veeva Systems News Summary

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Veeva beat Q1 earnings and revenue estimates, with EPS of $2.24 and revenue of $882.9 million, while also raising its fiscal 2027 outlook. Veeva Systems beats estimates on AI progress
• Positive Sentiment: Management highlighted AI momentum, including Falcon AI agents, CRM migration wins, and the Ostro acquisition, suggesting new growth drivers beyond the core platform. Veeva Systems Q1 Earnings Call Highlights AI Push & Higher Outlook
• Positive Sentiment: Several brokers remained constructive, including Barclays, Oppenheimer, RBC, Needham, BTIG, and Robert W. Baird, many of which kept buy/outperform ratings and elevated price targets. Veeva Systems (VEEV) Receives a Buy from Barclays
• Neutral Sentiment: Citigroup raised its target to $190 and maintained a neutral stance, while UBS and Canaccord also trimmed targets but stayed at neutral/hold, reflecting a more mixed Street view. Analyst updates
• Negative Sentiment: Despite the beat-and-raise quarter, the stock sold off as investors likely questioned how much of the AI optimism is already priced in and whether legacy CRM migration dynamics could pressure growth. Is Veeva Stock Undervalued At $170?
• Negative Sentiment: Goldman Sachs cut its price target to $165 and kept a sell rating, adding to the cautious tone around the name. Veeva Systems price target lowered by Goldman Sachs

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on the company. Raymond James Financial reissued an “outperform” rating and issued a $225.00 price objective on shares of Veeva Systems in a report on Thursday. BNP Paribas Exane reissued an “outperform” rating and issued a $285.00 price objective on shares of Veeva Systems in a report on Thursday. TD Cowen reissued a “buy” rating on shares of Veeva Systems in a report on Thursday. BTIG Research reissued a “buy” rating and issued a $340.00 price objective on shares of Veeva Systems in a report on Thursday. Finally, Truist Financial reissued a “buy” rating and issued a $262.00 price objective (down from $275.00) on shares of Veeva Systems in a report on Thursday, March 5th. Eighteen research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, Veeva Systems has a consensus rating of “Moderate Buy” and a consensus price target of $250.96.

Insider Activity at Veeva Systems

In other Veeva Systems news, Director Priscilla Hung sold 750 shares of the stock in a transaction that occurred on Thursday, April 30th. The stock was sold at an average price of $155.64, for a total transaction of $116,730.00. Following the completion of the transaction, the director owned 3,253 shares of the company’s stock, valued at $506,296.92. This represents a 18.74% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 10.60% of the stock is owned by insiders.

About Veeva Systems

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.